Latest filing published 30 Jul 2026 for AtriCure, Inc., €205k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Vinayak Doraiswamy on record concern AtriCure, Inc., in the capacity of board member. We count 18 filings; the first trade dates from 30 June 2021 and the latest from 28 July 2026.
Sales make up the whole of the open-market record (6 sales, €1.3M). Other entries cover 12 share grants. Since January 2026: no purchases and 2 sales on the market.
The newest entry dates from 30 July 2026: an open-market sale of €205k, in AtriCure, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations